CAS 1257213-50-5

Formel: C29H26N2O5

InChl: InChI=1S/C29H26N2O5/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33)/t19-/m1/s1

InChI Key: GQBRZBHEPUQRPL-LJQANCHMSA-N

SMILES: CC1=NOC(=C1NC(=O)O[C@H](C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O

BMS-986020

CAS: 1257213-50-5

BMS-986020

Formel: C₂₉H₂₆N₂O₅

Reinheit: ≥98%

Farbe und Form: Solid

Molekulargewicht: 482.53

Ref: 54-BUP05330

BMS-986020

CAS: 1257213-50-5

Formel: C₂₉H₂₆N₂O₅

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 482.5271

Ref: IN-DA000OJB

BMS-986020

CAS: 1257213-50-5

(R)-1-(4'-(3-Methyl-4-(((1-phenylethoxy)carbonyl)amino)isoxazol-5-yl)-[1,1'-biphenyl]-4-yl)cyclopropane-1-carboxylic acid

Formel: C₂₉H₂₆N₂O₅

Reinheit: 99%

Molekulargewicht: 482.53

Ref: IN-DG763610

BMS-986020

CAS: 1257213-50-5

BMS-986020 (AM152) is a selective antagonist of LPA1.

Formel: C₂₉H₂₆N₂O₅

Reinheit: 98.82% - >99.99%

Farbe und Form: Solid

Molekulargewicht: 482.53

Ref: TM-T4016

BMS-​986020

Kontrolliertes Produkt

CAS: 1257213-50-5

Applications BMS-​986020 is an LPA-1 antagonist which may be used in the inhibition and treatment of bleomycin-induced pulminary fibrosis.
References Smith, M. et al.: Org. Proc. Res. Dev., 21, 1859 (2017);

Formel: C₂₉H₂₆N₂O₅

Farbe und Form: Neat

Molekulargewicht: 482.53

Ref: TR-B701320

BMS 986020

CAS: 1257213-50-5

Potent and selective LPA1 antagonist

Formel: C₂₉H₂₆N₂O₅

Reinheit: Min. 97 Area-%

Farbe und Form: White Off-White Powder

Molekulargewicht: 482.53 g/mol

Ref: 3D-BB165375